| Literature DB >> 34262099 |
Bieke Decaesteker1,2, Winnok H De Vos3, Sofia Zanotti3,1,2, Suzanne Vanhauwaert1,2, Christophe Van Neste1,2, Volodimir Olexiouk1,2, Jolien Van Laere1,2, Marlies Verschuuren3, Joni Van der Meulen1,2,4, Liselot M Mus1,2,5, Kaat Durinck1,2, Laurentijn Tilleman2,6, Dieter Deforce2,6, Filip Van Nieuwerburgh2,6, Michael D Hogarty7,8, Frank Speleman9,10.
Abstract
MYCN is an oncogenic driver in neural crest-derived neuroblastoma and medulloblastoma. To better understand the early effects of MYCN activation in a neural-crest lineage context, we profiled the transcriptome of immortalized human retina pigment epithelial cells with inducible MYCN activation. Gene signatures associated with elevated MYC/MYCN activity were induced after 24 h of MYCN activation, which attenuated but sustained at later time points. Unexpectedly, MYCN activation was accompanied by reduced cell growth. Gene set enrichment analysis revealed a senescence-like signature with strong induction of p53 and p21 but in the absence of canonical hallmarks of senescence such as β-galactosidase positivity, suggesting incomplete cell fate commitment. When scrutinizing the putative drivers of this growth attenuation, differential gene expression analysis identified several regulators of nucleolar stress. This process was also reflected by phenotypic correlates such as cytoplasmic granule accrual and nucleolar coalescence. Hence, we propose that the induction of MYCN congests the translational machinery, causing nucleolar stress and driving cells into a transient pre-senescent state. Our findings shed new light on the early events induced by MYCN activation and may help unravelling which factors are required for cells to tolerate unscheduled MYCN overexpression during early malignant transformation.Entities:
Year: 2021 PMID: 34262099 DOI: 10.1038/s41598-021-93863-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379